SE393980B - Forfarande for framstellning av 5-(och7-) bensoylindolin-2-oner med terapeutisk verkan - Google Patents

Forfarande for framstellning av 5-(och7-) bensoylindolin-2-oner med terapeutisk verkan

Info

Publication number
SE393980B
SE393980B SE7306853A SE7306853A SE393980B SE 393980 B SE393980 B SE 393980B SE 7306853 A SE7306853 A SE 7306853A SE 7306853 A SE7306853 A SE 7306853A SE 393980 B SE393980 B SE 393980B
Authority
SE
Sweden
Prior art keywords
benzoylindolin
och7
ones
procedure
preparation
Prior art date
Application number
SE7306853A
Other languages
English (en)
Swedish (sv)
Inventor
Jr W J Welstead
H W Moran
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Publication of SE393980B publication Critical patent/SE393980B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B45/00Complex metal compounds of azo dyes
    • C09B45/02Preparation from dyes containing in o-position a hydroxy group and in o'-position hydroxy, alkoxy, carboxyl, amino or keto groups
    • C09B45/24Disazo or polyazo compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B35/00Disazo and polyazo dyes of the type A<-D->B prepared by diazotising and coupling
    • C09B35/02Disazo dyes
    • C09B35/039Disazo dyes characterised by the tetrazo component
    • C09B35/08Disazo dyes characterised by the tetrazo component the tetrazo component being a derivative of biphenyl

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Coloring (AREA)
SE7306853A 1972-05-17 1973-05-15 Forfarande for framstellning av 5-(och7-) bensoylindolin-2-oner med terapeutisk verkan SE393980B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25428472A 1972-05-17 1972-05-17

Publications (1)

Publication Number Publication Date
SE393980B true SE393980B (sv) 1977-05-31

Family

ID=22963675

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7306853A SE393980B (sv) 1972-05-17 1973-05-15 Forfarande for framstellning av 5-(och7-) bensoylindolin-2-oner med terapeutisk verkan

Country Status (17)

Country Link
JP (2) JPS5139222B2 (ru)
AT (1) AT323731B (ru)
BE (2) BE799612A (ru)
CA (1) CA1000715A (ru)
CH (1) CH577469A5 (ru)
DE (2) DE943075C (ru)
DK (1) DK139677B (ru)
ES (1) ES414802A1 (ru)
FI (1) FI56377C (ru)
FR (1) FR2184933B1 (ru)
GB (1) GB1432577A (ru)
IE (1) IE37641B1 (ru)
IL (1) IL42216A (ru)
NL (2) NL183187C (ru)
PH (1) PH9815A (ru)
SE (1) SE393980B (ru)
ZA (1) ZA733151B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5371842U (ru) * 1976-11-17 1978-06-15
US4221716A (en) * 1979-02-16 1980-09-09 A. H. Robins Company, Inc. Intermediate and process for the preparation of 7-acylindolin-2-ones
DE3300522A1 (de) * 1982-01-21 1983-07-28 Sandoz-Patent-GmbH, 7850 Lörrach 3,3-dialkyl- und 3,3-alkylen-indolinderivate, verfahren zu ihrer herstellung und pharmazeutische praeparate sie enthaltend
JPH0349563Y2 (ru) * 1985-08-31 1991-10-23

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH232507A (de) * 1941-02-18 1944-05-31 Chem Ind Basel Verfahren zur Herstellung eines Disazofarbstoffes.

Also Published As

Publication number Publication date
AU5584773A (en) 1974-11-21
FI56377C (fi) 1980-01-10
CH577469A5 (ru) 1976-07-15
DK139677B (da) 1979-03-26
DK139677C (ru) 1979-09-10
JPS5217466A (en) 1977-02-09
FR2184933B1 (ru) 1976-05-14
JPS4941366A (ru) 1974-04-18
IE37641B1 (en) 1977-09-14
ES414802A1 (es) 1976-02-01
DE2324767A1 (de) 1973-11-29
JPS5139222B2 (ru) 1976-10-26
FR2184933A1 (ru) 1973-12-28
BE524637A (ru)
BE799612A (fr) 1973-09-17
IE37641L (en) 1973-11-17
GB1432577A (en) 1976-04-22
NL183187C (nl) 1988-08-16
IL42216A (en) 1976-08-31
PH9815A (en) 1976-03-26
ZA733151B (en) 1974-04-24
NL183187B (nl) 1988-03-16
AT323731B (de) 1975-07-25
DE943075C (de) 1956-05-09
IL42216A0 (en) 1973-07-30
CA1000715A (en) 1976-11-30
NL7306832A (ru) 1973-11-20
JPS5910660B2 (ja) 1984-03-10
FI56377B (fi) 1979-09-28
NL90149C (ru)
DE2324767C2 (de) 1985-07-25

Similar Documents

Publication Publication Date Title
SE417205B (sv) Forfarande for framstellning av foreningar med autibiotisk verkan
SE405599B (sv) Forfarande for framstellning av pyridazinoner med terapeutisk verkan
NO140731C (no) Fremgangsmaate for fremstilling av dimetyleter
SE395149B (sv) Forfarande for framstellning av dibenso-tiepinylpiperazinderivat
SE401676B (sv) Forfarande for framstellning av dibensofuranderivat
SE380522B (sv) Forfarande for framstellning av (1- (p-klorbensoyl)-5-metoxi-2-metyl-3-indol) - acetoxiettiksyra med antiflogistisk verkan
SE382053B (sv) Forfarande for framstellning av bifenylylalkanoylaminopyridiner
NO137899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n (1h-tetrazol-5-yl)-kinaldamider
SE389671B (sv) Fforfarande for framstellning av 5-aroyl-pyrrolderivat med terapeutisk spec antiinflammatorisk verkan
SE395892B (sv) Forfarande for framstellning av piperidyl-bensimidazoliner med terapeutisk verkan
SE405851B (sv) Forfarande for framstellning av nya 2-aminometylenindanoner med analgetisk verkan
SE383151B (sv) Forfarande for framstellning av 1-hydroxi-2-pyridoner
SE397827B (sv) Forfarande for framstellning av 1-aminometyl-2,2-difenylcyklopropankarboxamidderivat med terapeutisk verkan
SE392722B (sv) Forfarande for framstellning av oxazolidinderivat med terapeutisk verkan
SE7514308L (sv) Forfarande for framstellning av tyrosinderivat med terapeutisk verkan
SE393111B (sv) Forfarande for framstellning av d-2-halogen-6-metyl-8-substituerad - ergolin
SE380272B (sv) Forfarande for framstellning av n-fosfonmetylglycin
SE410732B (sv) Analogiforfarande for framstellning av anilidderivat med terapeutisk verkan
FI56830B (fi) Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider
SE393808B (sv) Forfarande for framstellning av isomaltit
SE393980B (sv) Forfarande for framstellning av 5-(och7-) bensoylindolin-2-oner med terapeutisk verkan
SE385696B (sv) Nytt forfarande for framstellning av n-(1-etyl-alfa-pyrrolidylmetyl)-2-metoxi-5-sulfamidobensamid med terapeutiska egenskaper
SE7507887L (sv) Forfarande for framstellning av bensopyranforeningar med terapeutisk verkan.
SE380805B (sv) Forfarande for framstellning av oxazoler
SE391717B (sv) Forfarande for framstellning av 4-aryl-5-aminoalkyl-4-oxazolin-2-oner